MFN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.245800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.640000E-01
Normal-vs-Stage2
4.493200E-01
Normal-vs-Stage3
2.402600E-01
Normal-vs-Stage4
5.872600E-01
Stage1-vs-Stage2
8.996800E-01
Stage1-vs-Stage3
1.362190E-01
Stage1-vs-Stage4
5.109800E-01
Stage2-vs-Stage3
6.255800E-02
Stage2-vs-Stage4
3.961600E-01
Stage3-vs-Stage4
8.529900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.184600E-01
Normal-vs-AfricanAmerican
4.062600E-01
Normal-vs-Asian
1.250030E-01
Caucasian-vs-AfricanAmerican
5.281200E-01
Caucasian-vs-Asian
7.820400E-01
AfricanAmerican-vs-Asian
5.462000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.009000E-01
Normal-vs-Female
4.612800E-01
Male-vs-Female
2.085600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.128800E-01
Normal-vs-Age(41-60Yrs)
5.188000E-01
Normal-vs-Age(61-80Yrs)
3.979000E-01
Normal-vs-Age(81-100Yrs)
7.471900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.745400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.481200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.655800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.051600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.483700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.815200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.895400E-01
Normal-vs-Daily Drinker
3.193200E-01
Normal-vs-Weekly Drinker
1.102790E-01
Normal-vs-Occasional Drinker
2.361200E-01
Normal-vs-Social Drinker
3.206000E-01
Non Drinker-vs-Daily Drinker
3.184800E-01
Non Drinker-vs-Weekly Drinker
9.931400E-01
Non Drinker-vs-Occasional Drinker
1.491430E-01
Non Drinker-vs-Social Drinker
1.350170E-01
Daily Drinker-vs-Weekly Drinker
4.235600E-01
Daily Drinker-vs-Occasional Drinker
2.759700E-02
Daily Drinker-vs-Social Drinker
3.006400E-02
Weekly Drinker-vs-Occasional Drinker
2.362000E-01
Weekly Drinker-vs-Social Drinker
2.219200E-01
Occasional Drinker-vs-Social Drinker
8.675200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.857700E-02
Normal-vs-Grade 2
5.839900E-03
Normal-vs-Grade 3
8.784500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.095400E-03
Grade 1-vs-Grade 3
2.457400E-03
Grade 1-vs-Grade 4
9.857700E-02
Grade 2-vs-Grade 3
2.676600E-01
Grade 2-vs-Grade 4
5.839900E-03
Grade 3-vs-Grade 4
8.784500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.719600E-01
Normal-vs-NonDiabetic
4.145600E-01
Diabetic-vs-NonDiabetic
4.051000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.997800E-01
Normal-vs-NoPancreatitis
4.007600E-01
Pancreatitis-vs-NoPancreatitis
3.522800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.957000E-01
Normal-vs-N1
4.431400E-01
N0-vs-N1
3.360200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.877200E-01
Normal-vs-TP53-NonMutant
4.654400E-01
TP53-Mutant-vs-TP53-NonMutant
1.136250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
